ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      1.70%
      US Tech 100
      19,319.20
      2.45%
      Dow Jones
      42,025.19
      1.26%
      Brent Oil
      74.155
      -0.22%
      Bitcoin
      62,874.13
      -0.12%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Evofem Biosciences Inc (EVFM) Quote

      Evofem Biosciences Inc

      Evofem Biosciences Inc (EVFM)

      Evofem Biosciences Inc (QB)
      0.4782
      0.00
      (0.00%)
      Closed September 19 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.4782
      Bid
      0.465
      Ask
      0.468
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      2.716M
      Previous Close
      0.4782
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      5,680,000
      Dividend Yield
      -
      PE Ratio
      0.11
      Earnings Per Share (EPS)
      8.8
      Revenue
      18.22M
      Net Profit
      50M

      About Evofem Biosciences Inc

      Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmi... Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.evofem.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      EVFM Latest News

      More News

      Biopharma Partners with Telemed Firm and Shares are Climbing

      This company is striving to change the narratives around women's healthcare and offering solutions that reinforce and improve them. And shares are responding positively to a recent partnership To...

      June 27 2024
      AllPennyStocks.com

      Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

      Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 PR Newswire SAN DIEGO, June 1, 2023 Increased net product revenue more than 35% in the first quarter of 2023...

      June 01 2023
      PR Newswire (US)

      Evofem Biosciences Announces 1-for-125 Reverse Stock Split

      Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire SAN DIEGO, May 17, 2023 -- CUSIP number for Evofem will change to 30048L302 on May 18, 2023 -- -- Ticker symbol will change...

      May 17 2023
      PR Newswire (US)

      Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required

      Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required PR Newswire SAN DIEGO, April 12, 2023 — Improves Phexxi coverage for more than 5.8 million New York...

      April 12 2023
      PR Newswire (US)

      Evofem Biosciences Announces Cost Reduction Measures

      Evofem Biosciences Announces Cost Reduction Measures PR Newswire SAN DIEGO, March 21, 2023 – Company cuts management pay and lowers headcount to decrease operating costs – – Reductions align with...

      March 21 2023
      PR Newswire (US)

      Evofem Biosciences Appoints Interim Chief Financial Officer

      Evofem Biosciences Appoints Interim Chief Financial Officer PR Newswire SAN DIEGO, March 9, 2023 SAN DIEGO, March 9, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to...

      March 09 2023
      PR Newswire (US)

      Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering

      Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering PR Newswire SAN DIEGO, Feb. 28, 2023 -- Phexxi is the first and only hormone-free contraceptive offered by reproductive...

      February 28 2023
      PR Newswire (US)

      Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi

      Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi PR Newswire SAN DIEGO, Feb. 27, 2023 -- Evofem now has four Orange Book listed patents covering...

      February 27 2023
      PR Newswire (US)

      Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value

      Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value PR Newswire SAN DIEGO, Feb. 23, 2023 SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB:...

      February 23 2023
      PR Newswire (US)

      Costco Adds Phexxi® to Member Prescription Program

      Costco Adds Phexxi® to Member Prescription Program PR Newswire SAN DIEGO, Jan. 10, 2023 SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that...

      January 10 2023
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GSIWGarden Stage Ltd
      $ 8.17
      (259.91%)
      		70.61M
      ZEOZeo Energy Corporation
      $ 2.5995
      (128.03%)
      		58.93M
      TBIOTelesis Bio Inc
      $ 2.9201
      (114.71%)
      		45.9M
      NCINeo Concept International Group Holdings Ltd
      $ 0.84
      (71.43%)
      		12.66M
      VEROVenus Concept Inc
      $ 0.8475
      (68.66%)
      		19.71M
      HAOHaoxi Health Technology Ltd
      $ 0.83
      (-72.33%)
      		8.28M
      PGNYProgyny Inc
      $ 16.465
      (-32.63%)
      		19.16M
      NUZENuZee Inc
      $ 0.6998
      (-32.06%)
      		14.05M
      RGFReal Good Food Company Inc
      $ 0.308
      (-28.37%)
      		362.64k
      ALGSAligos Therapeutics Inc
      $ 10.18
      (-28.11%)
      		875.44k
      NVDANVIDIA Corporation
      $ 117.87
      (3.97%)
      		293.47M
      SQQQProShares UltraPro Short QQQ
      $ 7.76
      (-7.62%)
      		222.38M
      HOLOMicroCloud Hologram Inc
      $ 0.2328
      (15.08%)
      		120.04M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.1034
      (13.75%)
      		104.89M
      TSLATesla Inc
      $ 243.92
      (7.36%)
      		102.64M

      Discussion

      View Full Feed
      blackhawks blackhawks 3 minutes ago
      Because a nude dance of morbidly obese Jardiance users spilled over into the naked elbows ad shoot?
      Zorax Zorax 4 minutes ago
      That wasn't even your writing in the first sentence. Are you trying now to look like you have some sort of intelligence?
      timberwolf7 timberwolf7 4 minutes ago
      The LIE the economy is 'good'...

      Normally, the FED cuts rates to STIMULATE the economy, raises them to cool it down.
      So find it interesting to see the LIES that he cut because things are going 'well'.
      When in reality, the chatter has been for some time, the policies o
      Top Penny Top Penny 4 minutes ago
      Let's put this thing in its proper place, that way when the news hits the wires we can all have iced tea on Pluto!!!
      LTNC
      StayHumble StayHumble 5 minutes ago
      ALJ:wow 4+YearsTimelyFilings🟩Thus StillHere🟩2019

      --------------------------------------------V. ORDER------------------------------------------


      IT IS ORDERED this administrative proceeding IS DISMIS
      DBMM
      1vman 1vman 5 minutes ago
      *****🅰️🅰️🅰️ UBQUs management continues to ignore its shareholders

      Not a stock to invest in imo

      ENOUGH SAID
      UBQU
      delerious1 delerious1 5 minutes ago
      always best not to fall in love with a stock....I saw a pattern in the "other one" and bailed out with a tidy profit,,,still have it on my Streamer tho
      RONN
      jour_trader jour_trader 6 minutes ago
      Absolutely. Vyvanse may get delayed. OxyContin may get kicked down road for several years. We do know for certain what will be launching over next several months - that alone is a huge win. We haven’t seen any new positive BE trial for a while - lots of R&D being spent. Would love to see a couple in
      ELTP
      Steady_T Steady_T 6 minutes ago
      That is just silly. Even conditional approval gets NWBO a revenue stream. It would not impact EDEN development or the increase is treatment utilization that comes with EDEN.

      No way on God's green earth that NWBO "test all time lows...".

      Nice try but no cigar.
      NWBO
      StayHumble StayHumble 6 minutes ago
      This SEC Stock Hoax is shot 🚩🚩🚩

      DJT
      cojoboy cojoboy 7 minutes ago
      Would like to see .01 print tomorrow over there..
      RONN
      1vman 1vman 7 minutes ago
      *****🅰️🅰️🅰️ HCMC shareholders stuck with massive losses here thanks to the companies recent split

      ENOUGH SAID
      HCMC
      Yo-Yo Yo-Yo 7 minutes ago
      You too v!!! Enjoy your evening!!!!
      jammy32 jammy32 7 minutes ago
      Great call.
      ELTP
      Zorax Zorax 7 minutes ago
      The nude beach dance commercial showing mostly naked elbows I guess didn't make the censor cut.
      StayHumble StayHumble 8 minutes ago
      w0w🟩Corporate$UBQU"NO R/S +MERGER AQUISITION" 🟩ohBoy Yowza!
      https://x.com/CorporateUbqu/status/1765510100628726105?s=20
      https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
      UBQU
      delerious1 delerious1 8 minutes ago
      I think he has an ulterior motive for posting here
      HIRU
      Alpha14 Alpha14 8 minutes ago
      Why no news on the RNVA end...me no like ...
      RNVA
      Paulie Cashews Paulie Cashews 8 minutes ago
      You may be having a reasonable reaction to a never-ending barrage of bad news which you can do very little about.

      adserv.stocksite.com/images/paulie/ihsurvey.jpg

      www.investorshub.com/boards/board.asp?board_id=2581 Paulie's Pixel Palace
      jobynimble jobynimble 9 minutes ago
      Kinda wish they just file unaudited and do the typical otc p&d. Get some decent exit liquidity for everyone at least.

      That would mean others who bought so you could sell would wind up stuckholders…

      That would be okay with you?
      BOPO
      1vman 1vman 9 minutes ago
      *****🅰️🅰️🅰️ DBMM A basement dweller investment , like holding the bag and lose money this is the investment to make --- Wh👀ps !



      ENOUGH SAID
      DBMM
      I-Glow I-Glow 9 minutes ago
      Baez doesn't have a business footprint - most of the information about Baez is from the Park created press releases and posts on Twitter (X).

      The Bloxcross website doesn't provide an address or phone number - that is very odd.

      Who is using Bloxcross payment system.
      SPZI
      arachnodude arachnodude 9 minutes ago
      From the next paragraph, EOT, KBLB elaborates:

      Management has undertaken steps as part of a plan to improve operations with the goal of sustaining our operations for the next twelve months and beyond. These steps include (a) raising additional capital and/or obtaining financing; (b) c
      KBLB
      Jbuffett Jbuffett 10 minutes ago
      I can't believe the same folks are still hanging in to titan. If you haven't sold out... It's over... Time to move on to another company. Check out Monogram robotics. Ortho robotics is where the market is heading...
      TMDIF
      crazy horse 0 crazy horse 0 10 minutes ago
      JD Vance: The Immigration Crisis, How Polls Are Used to Fool You, and the Left’s Plan to Stop Trump

      https://tuckercarlson.com/jd-vance-interview?utm_campaign=20240918_sept18dailybriefnonsubs&utm_medium=email&utm_source=iterable&utm_content=jdvance

      Your Recent History

      NASDAQ
      EVFM
      Evofem Biosciences
      Delayed Upgrade Clock